Related Experiment Video
Updated: Mar 29, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Hepatitis D Virus Pathogenesis: A Sense of Complications
Yann Haennel1, Thomas F Baumert1,2,3,4, Joachim Lupberger1
1Institute of Translational Medicine and Liver Diseases (ITM), University of Strasbourg, Inserm, UMR_S1110, 67000 Strasbourg, France.
Hepatitis D virus (HDV) causes severe liver disease and cancer, rapidly progressing to cirrhosis. Understanding HDV pathogenesis is crucial for developing new treatments and screening strategies.
Area of Science:
- Hepatology and Virology
- Oncology
- Immunology
Background:
- Hepatitis D virus (HDV) is a significant cause of severe chronic viral hepatitis, affecting millions globally.
- HDV infection exacerbates hepatitis B virus (HBV) related liver disease, accelerating progression to cirrhosis and hepatocellular carcinoma (HCC).
- Mechanisms underlying HDV pathogenicity and its role in HCC development remain incompletely understood.
Purpose of the Study:
- To review current knowledge on HDV-induced liver injuries and their contribution to oncogenic pressure.
- To summarize the molecular basis of HDV pathogenesis and its clinical implications.
- To highlight the direct and indirect roles of HDV in HCC development.
Main Methods:
- Comprehensive literature review of studies on HDV pathogenesis and clinical outcomes.
- Analysis of viral sensing, innate immune responses, and molecular mechanisms of HDV.
- Synthesis of evidence linking chronic HDV infection to liver cirrhosis and HCC.
Main Results:
- HDV infection leads to rapid liver inflammation, fibrosis, and cirrhosis, increasing cancer risk.
- Evidence supports both direct and indirect contributions of HDV to hepatocellular carcinoma development.
- HDV has been classified as a group 1 carcinogenic agent, underscoring its oncogenic potential.
Conclusions:
- HDV is a potent driver of liver disease severity and HCC, necessitating urgent therapeutic interventions.
- Routine HDV screening in chronic hepatitis B patients is recommended.
- Intensified HCC surveillance is crucial for individuals with chronic hepatitis D infection.
More Related Videos
11:14Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Hepatitis
Viruses with RNA Genomes
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Diphtheria
Cytomegalovirus Disease
Retroviruses